Their compounding status under federal law is still being determined: removal from the Category 2 restricted list takes effect April 23, 2026, and the FDAs Pharmacy Compounding Advisory Committee will review whether to officially clear any of them at its July 23-24, 2026 meeting
They are regulated primarily by state boards of pharmacy and must comply with USP 797 standards
11 , e2100596 (2022)
Toriumi, K., Miyashita, M., Suzuki, K., Yamasaki, N., Yasumura, M., Horiuchi, Y., Yoshikawa, A., Asakura, M., Usui, N., Itokawa, M., & Arai, M
PRIVACY STATEMENT The New Hazlett Center for the Performing Arts is committed to protecting your privacy as a visitor to this Website and as our customer
Clin Hemorheol.Microcirc